-
1
-
-
84872967522
-
Cancer statistics, 2013
-
Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11-30.
-
(2013)
CA Cancer J Clin
, vol.63
, Issue.1
, pp. 11-30
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
2
-
-
0029089012
-
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group
-
Ginsberg RJ, Rubinstein LV (1995) Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60(3):615-622.
-
(1995)
Ann Thorac Surg
, vol.60
, Issue.3
, pp. 615-622
-
-
Ginsberg, R.J.1
Rubinstein, L.V.2
-
3
-
-
77949520655
-
Stereotactic body radiation therapy for inoperable early stage lung cancer
-
Timmerman R, et al. (2010) Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303(11):1070-1076.
-
(2010)
JAMA
, vol.303
, Issue.11
, pp. 1070-1076
-
-
Timmerman, R.1
-
4
-
-
74549188119
-
Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications
-
Chi A, et al. (2010) Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications. Radiother Oncol 94(1):1-11.
-
(2010)
Radiother Oncol
, vol.94
, Issue.1
, pp. 1-11
-
-
Chi, A.1
-
5
-
-
0028811996
-
Incidence of local recurrence and second primary tumors in resected stage I lung cancer
-
Martini N, et al. (1995) Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 109(1):120-129.
-
(1995)
J Thorac Cardiovasc Surg
, vol.109
, Issue.1
, pp. 120-129
-
-
Martini, N.1
-
6
-
-
84925709292
-
Lung stereotactic body radiation therapy: Regional nodal failure is not predicted by tumor size
-
Marwaha G, Stephans KL, Woody NM, Reddy CA, Videtic GM (2014) Lung stereotactic body radiation therapy: Regional nodal failure is not predicted by tumor size. J Thorac Oncol 9(11):1693-1697.
-
(2014)
J Thorac Oncol
, vol.9
, Issue.11
, pp. 1693-1697
-
-
Marwaha, G.1
Stephans, K.L.2
Woody, N.M.3
Reddy, C.A.4
Videtic, G.M.5
-
7
-
-
0347444723
-
MicroRNAs: Genomics, biogenesis, mechanism, and function
-
Bartel DP (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116(2):281-297.
-
(2004)
Cell
, vol.116
, Issue.2
, pp. 281-297
-
-
Bartel, D.P.1
-
8
-
-
27244434788
-
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia
-
Calin GA, et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353(17):1793-1801.
-
(2005)
N Engl J Med
, vol.353
, Issue.17
, pp. 1793-1801
-
-
Calin, G.A.1
-
9
-
-
23844555119
-
MicroRNA gene expression deregulation in human breast cancer
-
Iorio MV, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65(16):7065-7070.
-
(2005)
Cancer Res
, vol.65
, Issue.16
, pp. 7065-7070
-
-
Iorio, M.V.1
-
10
-
-
33644819964
-
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
-
Yanaihara N, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9(3):189-198.
-
(2006)
Cancer Cell
, vol.9
, Issue.3
, pp. 189-198
-
-
Yanaihara, N.1
-
11
-
-
37349096992
-
MicroRNA signature predicts survival and relapse in lung cancer
-
Yu SL, et al. (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13(1):48-57.
-
(2008)
Cancer Cell
, vol.13
, Issue.1
, pp. 48-57
-
-
Yu, S.L.1
-
12
-
-
84898430214
-
MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer
-
Valeri N, et al. (2014) MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer. Cancer Cell 25(4): 469-483.
-
(2014)
Cancer Cell
, vol.25
, Issue.4
, pp. 469-483
-
-
Valeri, N.1
-
13
-
-
84886420851
-
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma
-
Meng W, et al. (2013) MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma. Clin Cancer Res 19(19):5423-5433.
-
(2013)
Clin Cancer Res
, vol.19
, Issue.19
, pp. 5423-5433
-
-
Meng, W.1
-
14
-
-
0026557270
-
Characterization of a novel tumor necrosis factor-alpha-induced endothelial primary response gene
-
Wolf FW, et al. (1992) Characterization of a novel tumor necrosis factor-alpha-induced endothelial primary response gene. JBiolChem267(2):1317-1326.
-
(1992)
JBiolChem
, vol.267
, Issue.2
, pp. 1317-1326
-
-
Wolf, F.W.1
-
15
-
-
14844299483
-
Cloning of two rat PDIP1 related genes and their interactions with proliferating cell nuclear antigen
-
Zhou J, et al. (2005) Cloning of two rat PDIP1 related genes and their interactions with proliferating cell nuclear antigen. J Exp Zoolog A Comp Exp Biol 303(3):227-240.
-
(2005)
J Exp Zoolog a Comp Exp Biol
, vol.303
, Issue.3
, pp. 227-240
-
-
Zhou, J.1
-
16
-
-
70350721797
-
RhoB induces apoptosis via direct interaction with TNFAIP1 in HeLa cells
-
Kim DM, et al. (2009) RhoB induces apoptosis via direct interaction with TNFAIP1 in HeLa cells. Int J Cancer 125(11):2520-2527.
-
(2009)
Int J Cancer
, vol.125
, Issue.11
, pp. 2520-2527
-
-
Kim, D.M.1
-
17
-
-
0029834067
-
Partnership between DPC4and SMAD proteins in TGF-beta signalling pathways
-
Lagna G, Hata A, Hemmati-Brivanlou A, Massagué J (1996) Partnership between DPC4and SMAD proteins in TGF-beta signalling pathways. Nature 383(6603):832-836.
-
(1996)
Nature
, vol.383
, Issue.6603
, pp. 832-836
-
-
Lagna, G.1
Hata, A.2
Hemmati-Brivanlou, A.3
Massagué, J.4
-
18
-
-
0034644472
-
TGFbeta signaling in growth control, cancer, and heritable disorders
-
Massagué J, Blain SW, Lo RS (2000) TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103(2):295-309.
-
(2000)
Cell
, vol.103
, Issue.2
, pp. 295-309
-
-
Massagué, J.1
Blain, S.W.2
Lo, R.S.3
-
19
-
-
0030593038
-
DPC4, a candidate tumor suppressor gene at human chromosome18q21.1
-
Hahn SA, et al. (1996) DPC4, a candidate tumor suppressor gene at human chromosome18q21.1. Science 271(5247):350-353.
-
(1996)
Science
, vol.271
, Issue.5247
, pp. 350-353
-
-
Hahn, S.A.1
-
20
-
-
0033587156
-
Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis
-
Miyaki M, et al. (1999) Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 18(20):3098-3103.
-
(1999)
Oncogene
, vol.18
, Issue.20
, pp. 3098-3103
-
-
Miyaki, M.1
-
21
-
-
84870623242
-
Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer
-
Hirata H, et al. (2012) Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer. PLoS One 7(11):e51056.
-
(2012)
PLoS One
, vol.7
, Issue.11
, pp. e51056
-
-
Hirata, H.1
-
22
-
-
84873518138
-
The oncogenic role of microRNA-130a/301a/454 in human colorectal cancer via targeting Smad4 expression
-
Liu L, et al. (2013) The oncogenic role of microRNA-130a/301a/454 in human colorectal cancer via targeting Smad4 expression. PLoS One 8(2):e55532.
-
(2013)
PLoS One
, vol.8
, Issue.2
, pp. e55532
-
-
Liu, L.1
-
23
-
-
84884481585
-
MicroRNA-373 is upregulated and targets TNFAIP1 in human gastric cancer, contributing to tumorigenesis
-
Zhang X, et al. (2013) MicroRNA-373 is upregulated and targets TNFAIP1 in human gastric cancer, contributing to tumorigenesis. Oncol Lett 6(5):1427-1434.
-
(2013)
Oncol Lett
, vol.6
, Issue.5
, pp. 1427-1434
-
-
Zhang, X.1
-
24
-
-
84873629276
-
MicroRNA-372 maintains oncogene characteristics by targeting TNFAIP1and affects NFêB signaling in human gastric carcinoma cells
-
Zhou C, et al. (2013) microRNA-372 maintains oncogene characteristics by targeting TNFAIP1and affects NFêB signaling in human gastric carcinoma cells. Int J Oncol 42(2):635-642.
-
(2013)
Int J Oncol
, vol.42
, Issue.2
, pp. 635-642
-
-
Zhou, C.1
-
26
-
-
34248591612
-
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
-
Roberts PJ, Der CJ (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26(22):3291-3310.
-
(2007)
Oncogene
, vol.26
, Issue.22
, pp. 3291-3310
-
-
Roberts, P.J.1
Der, C.J.2
-
27
-
-
84867393599
-
MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation
-
Romano G, et al. (2012) MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation. Proc Natl Acad Sci USA 109(41):16570-16575.
-
(2012)
Proc Natl Acad Sci USA
, vol.109
, Issue.41
, pp. 16570-16575
-
-
Romano, G.1
-
28
-
-
84904566141
-
MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G?/S transition and apoptosis by targeting p21(WAF1/CIP1)
-
Wang H, Zhu LJ, Yang YC, Wang ZX, Wang R (2014) MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G?/S transition and apoptosis by targeting p21(WAF1/CIP1). Br J Cancer 111(2):339-354.
-
(2014)
Br J Cancer
, vol.111
, Issue.2
, pp. 339-354
-
-
Wang, H.1
Zhu, L.J.2
Yang, Y.C.3
Wang, Z.X.4
Wang, R.5
-
29
-
-
84965184551
-
Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients
-
Zhu D, et al. (2014) Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients. Diagn Pathol 9(1):198.
-
(2014)
Diagn Pathol
, vol.9
, Issue.1
, pp. 198
-
-
Zhu, D.1
-
30
-
-
70349320158
-
Causes and consequences of microRNA dysregulation in cancer
-
Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10(10):704-714.
-
(2009)
Nat Rev Genet
, vol.10
, Issue.10
, pp. 704-714
-
-
Croce, C.M.1
-
31
-
-
45149128115
-
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target
-
Wang Y, et al. (2008) Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J Biol Chem 283(19):13205-13215.
-
(2008)
J Biol Chem
, vol.283
, Issue.19
, pp. 13205-13215
-
-
Wang, Y.1
-
32
-
-
84880826932
-
MicroRNA-224 targets SMAD family member 4 to promote cell proliferation and negatively influence patient survival
-
Wang Y, et al. (2013) MicroRNA-224 targets SMAD family member 4 to promote cell proliferation and negatively influence patient survival. PLoS One 8(7):e68744.
-
(2013)
PLoS One
, vol.8
, Issue.7
, pp. e68744
-
-
Wang, Y.1
-
33
-
-
84883470363
-
MicroRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2
-
Liao WT, et al. (2013) microRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2. Clin Cancer Res 19(17):4662-4672.
-
(2013)
Clin Cancer Res
, vol.19
, Issue.17
, pp. 4662-4672
-
-
Liao, W.T.1
-
34
-
-
84865379684
-
MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells
-
Huang L, et al. (2012) MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells. Biochem Biophys Res Commun 425(2):127-133.
-
(2012)
Biochem Biophys Res Commun
, vol.425
, Issue.2
, pp. 127-133
-
-
Huang, L.1
-
35
-
-
84900413202
-
Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer
-
Goto Y, et al. (2014) Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer. FEBS Lett 588(10):1973-1982.
-
(2014)
FEBS Lett
, vol.588
, Issue.10
, pp. 1973-1982
-
-
Goto, Y.1
-
36
-
-
84901062391
-
MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1
-
Lin ZY, et al. (2014) MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1. Int J Cancer 135(3):541-550.
-
(2014)
Int J Cancer
, vol.135
, Issue.3
, pp. 541-550
-
-
Lin, Z.Y.1
-
37
-
-
0034604110
-
Role of transforming growth factor beta in human disease
-
Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342(18):1350-1358.
-
(2000)
N Engl J Med
, vol.342
, Issue.18
, pp. 1350-1358
-
-
Blobe, G.C.1
Schiemann, W.P.2
Lodish, H.F.3
-
38
-
-
27944445472
-
Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells
-
Anumanthan G, et al. (2005) Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells. Br J Cancer 93(10):1157-1167.
-
(2005)
Br J Cancer
, vol.93
, Issue.10
, pp. 1157-1167
-
-
Anumanthan, G.1
-
39
-
-
0034604108
-
Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers
-
Yanagisawa K, et al. (2000) Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers. Oncogene 19(19):2305-2311.
-
(2000)
Oncogene
, vol.19
, Issue.19
, pp. 2305-2311
-
-
Yanagisawa, K.1
-
40
-
-
0029933642
-
Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers
-
Nagatake M, et al. (1996) Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res 56(12):2718-2720.
-
(1996)
Cancer Res
, vol.56
, Issue.12
, pp. 2718-2720
-
-
Nagatake, M.1
-
41
-
-
84893411121
-
Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel
-
Scarpa A, et al. (2013) Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel. PLoS One 8(11):e80478.
-
(2013)
PLoS One
, vol.8
, Issue.11
, pp. e80478
-
-
Scarpa, A.1
-
42
-
-
84861147473
-
A comprehensive survey of Ras mutations in cancer
-
Prior IA, Lewis PD, Mattos C (2012) A comprehensive survey of Ras mutations in cancer. Cancer Res 72(10):2457-2467.
-
(2012)
Cancer Res
, vol.72
, Issue.10
, pp. 2457-2467
-
-
Prior, I.A.1
Lewis, P.D.2
Mattos, C.3
-
43
-
-
84915733522
-
E2F1 induces miR-224/452 expression to drive EMT through TXNIP downregulation
-
Knoll S, et al. (2014) E2F1 induces miR-224/452 expression to drive EMT through TXNIP downregulation. EMBO Rep 15(12):1315-1329.
-
(2014)
EMBO Rep
, vol.15
, Issue.12
, pp. 1315-1329
-
-
Knoll, S.1
|